UT Southwestern Researcher Tells His CAR-T Therapy Story Ahead of Myeloma Trial
As UT Southwestern and Celgene Corporation join efforts to launch a new clinical trial to evaluate a chimeric antigen receptor T-cell therapy,…
News
Adelson Research Foundation Supports 3-Year Myeloma Funding Initiative
The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF), a private organization funding collaborative translational science, recently launched the Adelson Program in…
Pomalyst Combo Delays Disease Progression in Relapsed or Refractory Myeloma Patients in Phase 3 Trial
A combination treatment including Pomalyst (pomalidomide) significantly extended the time until disease progression or death in patients with relapsed or refractory multiple myeloma who were…
PT-112 Receives Orphan Drug Status for Advanced Multiple Myeloma
PT-112, an investigational small molecule that promotes cancer cell death, has been designated an orphan drug by the U.S. Food and Drug Administration (FDA) for…
Most Canadians Wouldn’t Know Where to Turn If Diagnosed With Blood Cancer, Survey Finds
Some 68 percent of Canadians would feel helpless if they or someone close to them received a blood cancer diagnosis, found a recent poll commissioned…
Multiple Myeloma Patients in UK Gain Access to Ninlaro through Cancer Drugs Fund
Multiple myeloma patients in the United Kingdom can now potentially benefit from a new oral pill sold as Ninlaro…
Stem Cell Transplants Better Than New Therapies at Delaying Myeloma Progression, Analysis Finds
In an era of new therapies with unprecedented efficacy, high-dose therapy with melphalan followed by autologous stem cell transplant (HDT/ASCT) is still associated with better progression-free…
Ethyol Pretreatment Reduces Gastrointestinal Side Effects of Bone Marrow Transplant in Myeloma Patients
Pretreating multiple myeloma patients with Ethyol (amifostine) prior to a stem cell transplant significantly reduces the transplant therapy’s gastrointestinal toxicity without compromising its efficacy, a…
Myeloma Research Foundation and Karyopharm Hoping Myeloma Therapy Progress Continues
The Multiple Myeloma Research Foundation and Karyopharm Therapeutics are hoping that 2018 will be as momentous a year as 2017 in their collaborative effort to develop…
Nanoparticle-targeted Phototherapy Tested in Mice; Might Be Multiple Myeloma Therapy Someday
Animal studies have shown that a new treatment strategy using phototherapy might be used to treat inaccessible cancers, including multiple myeloma. The therapy makes use…
